Home Page
Site Map
Newsletter
About
Creabilis
Mission &
Strategy
Board of
Directors
Management
Investors
History
Pipeline
Projects
Creabilis Science
MiniPEGylation
Targets
Drug Discovery
Contacts
Information Request
Press release
CREABILIS
therapeutics
Announces Establishment of Scientific Advisory Board
2008-10-13
- Leading Experts in Dermatology to Advise Company on Development of Product for Psoriasis and Dermatitis
CREABILIS
therapeutics
Appoints Anthony Wilson as its New Chief Executive Officer
2008-06-16
- CREABILIS
therapeutics
SpA, an emerging specialty pharmaceutical company focused on dermatology, today announced the appointment of Tony Wilson as Chief Executive Officer with immediate effect.
CREABILIS
therapeutics
Raises 20 Million in a Series A Funding Led by Sofinnova Partners and in Collaboration with NeoMed
2008-06-06
- CREABILIS
therapeutics
SpA, an emerging specialty pharmaceutical company focused on dermatology, today announces that it has raised a total of 20 million in a Series A round of funding.
Pipeline
CT400
The CT400 program is aimed at developing inhibitors of HGMB- ...
CT200
The product is being developed for Behçet ...
CT335
A new systemic treatment for Behçet's Disease. ...
more
News & Events
2008-10-13
CREABILIS
therapeutics
Announces Establishment of Sci ...
2008-06-16
CREABILIS
therapeutics
Appoints Anthony Wilson as its ...
2008-06-06
CREABILIS
therapeutics
Raises 20 Million in a Series ...
more